Twelve years ago, the FDA approved Hologic’s digital breast tomosynthesis (DBT) system – sometimes incorrectly referred to as 3D mammography – as […]
Twelve years ago, the FDA approved Hologic’s digital breast tomosynthesis (DBT) system – sometimes incorrectly referred to as 3D mammography – as […]
When he was growing up in Budapest, Hungary, Peter Kecskemethy would spend time at one of the city’s largest hospitals […]
Eleven years ago, we reviewed the Pulitzer Prize-winning book, The Emperor of All Maladies: A Biography of Cancer, by oncologist Dr Siddhartha Mukherjee (© […]
Digital breast tomosynthesis (DBT) was approved by the FDA in 2011 as a screening modality for the early detection of […]
Delphinus Medical Technologies has just announced the closing of a $30 million investment to fast-track commercialisation of its SoftVue automated breast ultrasound […]
On the eve of Breast Cancer Awareness Month comes the news that Katie Couric, the former CBS Evening News anchor, was diagnosed with […]
Full-field digital mammography (FFDM) has been the “go to” imaging modality to screen for early detection of breast cancer for […]
Five years ago, we reported that the United States Patent and Trademark Office (USPTO) had awarded CapeRay a key patent to protect our novel dual-modality […]
In 1985, Dr Jay Stein and his good friend David Ellenbogen teamed up to co-found Hologic with 12 employees and the intention […]
It was five years ago that we published a key article in Diagnostics, an open-access journal, in which we described our dual-modality […]